222 related articles for article (PubMed ID: 28301749)
1. Sizing Up Protein-Ligand Complexes: The Rise of Structural Mass Spectrometry Approaches in the Pharmaceutical Sciences.
Eschweiler JD; Kerr R; Rabuck-Gibbons J; Ruotolo BT
Annu Rev Anal Chem (Palo Alto Calif); 2017 Jun; 10(1):25-44. PubMed ID: 28301749
[TBL] [Abstract][Full Text] [Related]
2. Ion mobility-mass spectrometry of intact protein--ligand complexes for pharmaceutical drug discovery and development.
Niu S; Rabuck JN; Ruotolo BT
Curr Opin Chem Biol; 2013 Oct; 17(5):809-17. PubMed ID: 23856053
[TBL] [Abstract][Full Text] [Related]
3. Native mass spectrometry as a tool in structural biology.
Lorenzen K; van Duijn E
Curr Protoc Protein Sci; 2010 Nov; Chapter 17():Unit17.12. PubMed ID: 21104986
[TBL] [Abstract][Full Text] [Related]
4. Ion mobility-mass spectrometry as a tool to investigate protein-ligand interactions.
Göth M; Pagel K
Anal Bioanal Chem; 2017 Jul; 409(18):4305-4310. PubMed ID: 28500372
[TBL] [Abstract][Full Text] [Related]
5. Detection Technologies. Ambient mass spectrometry.
Cooks RG; Ouyang Z; Takats Z; Wiseman JM
Science; 2006 Mar; 311(5767):1566-70. PubMed ID: 16543450
[TBL] [Abstract][Full Text] [Related]
6. Native Mass Spectrometry in Fragment-Based Drug Discovery.
Pedro L; Quinn RJ
Molecules; 2016 Jul; 21(8):. PubMed ID: 27483215
[TBL] [Abstract][Full Text] [Related]
7. Ion mobility mass spectrometry of proteins and protein assemblies.
Uetrecht C; Rose RJ; van Duijn E; Lorenzen K; Heck AJ
Chem Soc Rev; 2010 May; 39(5):1633-55. PubMed ID: 20419213
[TBL] [Abstract][Full Text] [Related]
8. Understanding protein-drug interactions using ion mobility-mass spectrometry.
Eyers CE; Vonderach M; Ferries S; Jeacock K; Eyers PA
Curr Opin Chem Biol; 2018 Feb; 42():167-176. PubMed ID: 29331721
[TBL] [Abstract][Full Text] [Related]
9. Ion Mobility-Mass Spectrometry to Evaluate the Effects of Protein Modification or Small Molecule Binding on Protein Dynamics.
Tomlinson LJ; Eyers CE
Methods Mol Biol; 2020; 2084():179-190. PubMed ID: 31729661
[TBL] [Abstract][Full Text] [Related]
10. Imaging and spatially resolved quantification of drug distribution in tissues by mass spectrometry.
Prideaux B; Lenaerts A; Dartois V
Curr Opin Chem Biol; 2018 Jun; 44():93-100. PubMed ID: 29957376
[TBL] [Abstract][Full Text] [Related]
11. Surface induced dissociation: dissecting noncovalent protein complexes in the gas phase.
Zhou M; Wysocki VH
Acc Chem Res; 2014 Apr; 47(4):1010-8. PubMed ID: 24524650
[TBL] [Abstract][Full Text] [Related]
12. Native mass spectrometry-A valuable tool in structural biology.
Barth M; Schmidt C
J Mass Spectrom; 2020 Oct; 55(10):e4578. PubMed ID: 32662584
[TBL] [Abstract][Full Text] [Related]
13. Current applications of liquid chromatography/mass spectrometry in pharmaceutical discovery after a decade of innovation.
Ackermann BL; Berna MJ; Eckstein JA; Ott LW; Chaudhary AK
Annu Rev Anal Chem (Palo Alto Calif); 2008; 1():357-96. PubMed ID: 20636083
[TBL] [Abstract][Full Text] [Related]
14. Infrared multiphoton dissociation in quadrupole ion traps.
Brodbelt JS; Wilson JJ
Mass Spectrom Rev; 2009; 28(3):390-424. PubMed ID: 19294735
[TBL] [Abstract][Full Text] [Related]
15. Molecular recognition by mass spectrometry.
Di Tullio A; Reale S; De Angelis F
J Mass Spectrom; 2005 Jul; 40(7):845-65. PubMed ID: 16034845
[TBL] [Abstract][Full Text] [Related]
16. Recent instrumental progress in mass spectrometry: advancing resolution, accuracy, and speed of drug detection.
Thevis M; Volmer DA
Drug Test Anal; 2012; 4(3-4):242-5. PubMed ID: 22374710
[TBL] [Abstract][Full Text] [Related]
17. Applications of mass spectrometry in drug metabolism: 50 years of progress.
Wen B; Zhu M
Drug Metab Rev; 2015 Feb; 47(1):71-87. PubMed ID: 25639893
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometry imaging in drug development.
Nilsson A; Goodwin RJ; Shariatgorji M; Vallianatou T; Webborn PJ; Andrén PE
Anal Chem; 2015 Feb; 87(3):1437-55. PubMed ID: 25526173
[No Abstract] [Full Text] [Related]
19. Ion mobility coupled to native mass spectrometry as a relevant tool to investigate extremely small ligand-induced conformational changes.
Stojko J; Fieulaine S; Petiot-Bécard S; Van Dorsselaer A; Meinnel T; Giglione C; Cianférani S
Analyst; 2015 Nov; 140(21):7234-45. PubMed ID: 26401526
[TBL] [Abstract][Full Text] [Related]
20. Application of the Exactive Plus EMR for automated protein-ligand screening by non-covalent mass spectrometry.
Maple HJ; Scheibner O; Baumert M; Allen M; Taylor RJ; Garlish RA; Bromirski M; Burnley RJ
Rapid Commun Mass Spectrom; 2014 Jul; 28(13):1561-8. PubMed ID: 24861608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
